Transcriptional Responses to Cinnamaldehyde in Mycobacterium tuberculosis
Background: Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis.
Objectives: Development of the drug resistance is becoming a threat to disease control, which underscores need for new agents targeting M. tuberculosis.
Materials and Methods: In this study, analysis of gene expression was performed using real-time polymerase chain reaction (RT- PCR).
Results: Results of the current study showed that the minimum inhibitory concentration value of cinnamaldehyde against M. tuberculosis was 200 µg/mL. Moreover, RT-PCR data showed that a total of 25 genes were regulated by the cinnamaldehyde. Of these, 12 genes were up-regulated, and 13 genes were down-regulated.
Conclusions: Cinnamaldehyde is a pattern to expand the new anti-TB drugs, because the targets of the cinnamaldehyde are different from those of anti-tubercular agents.
Keywords: Antimycobacterial Activity; Cinnamaldehyde, Medicinal Plant; Mycobacterium tuberculosis
The tuberculosis (TB) disease is still among world’s leading infectious diseases (1). Although accessible antimicrobial agents are effective at eradicating infections, there are issues with emergence of drug-resistant M. tuberculosis strains (2). Additionally, increased incidence of HIV infection has been shown to be associated with an increased mortality rate (3).
Some plants have been proven to be the sources of useful drugs. Cinnamaldehyde (Figure 1) has been elicited from several plants, such as Cinnamomum cassia. The cinnamaldehyde has been used in traditional medicine and has been demonstrated to suppress the growth of Clostridium botulinum (4), and Staphylococcus aureus (5). A few studies have reported on mechanisms underlying the effects of antimycobacterial agents (6).
Chemical Formula of Cinnamaldehdye
The aim of this study was to determine antimycobacterial effects of cinnamaldehyde.
3. Materials and Methods
The cinnamaldehyde was supplied by Sigma-Aldrich chemical company. Mycobacterium tuberculosis was obtained from Zabol University of Medical Sciences. Mycobacterium tuberculosis was grown in a flask (100 mL) containing the Middlebrook 7H9 medium. Then, 1 mL of culture was placed in each of tubes and exposed to different concentrations of the cinnamaldehyde. Mycobacterium tuberculosis was grown in the Middlebrook 7H9 broth. The drug treatments were carried out by adding stock solution to one of the cultures. Real-time PCR reactions were carried out using a Rotor-Gene 6000. Primers used are shown in Table 1. Analyses were carried out using the relative expression software tool (RESTª) software as described by Pfaffl et al. (7).
3.1. Bacterial Strains and Reagents
3.2. Growth Curve of Mycobacterium tuberculosis With Different Concentrations of the Cinnamaldehyde
3.3. Cell Culture and Treatment by Quantitative Real-Time Polymerase Chain Reaction
3.4. Quantification of Gene Expression by Real-Time Polymerase Chain Reaction
The cinnamaldehyde was supplied by Sigma-Aldrich chemical company. Mycobacterium tuberculosis was obtained from Zabol University of Medical Sciences.
Mycobacterium tuberculosis was grown in a flask (100 mL) containing the Middlebrook 7H9 medium. Then, 1 mL of culture was placed in each of tubes and exposed to different concentrations of the cinnamaldehyde.
Mycobacterium tuberculosis was grown in the Middlebrook 7H9 broth. The drug treatments were carried out by adding stock solution to one of the cultures.
Real-time PCR reactions were carried out using a Rotor-Gene 6000. Primers used are shown in Table 1. Analyses were carried out using the relative expression software tool (RESTª) software as described by Pfaffl et al. (7).
The bacteria were exposed to the different concentrations of cinnamaldehyde. The results in Figure 2 showed that 200 μg/mL of the cinnamaldehyde was the minimum inhibitory concentration (MIC) of the cinnamaldehyde, which inhibited the growth of M. tuberculosis. Therefore, M. tuberculosis was exposed to 200 μg/mL of the cinnamaldehyde in order to promote an alteration in gene expression of bacteria.
Real-time PCR was used to analyze gene expression in M. tuberculosis. Overall, there were 25 genes differentially regulated by the cinnamaldehyde. Among these, 12 genes exhibited a significant increase in the transcription and 13 exhibited a significant decrease in the transcription (Table 2).
Mycobacterium tuberculosis Exposed to Different Concentrations of Cinnamaldehdye
Real-Time Polymerase Chain Reaction Analysis of Gene Expressiona
Four genes of frdA, frdB, frdC and frdD were down-regulated by 3.1-fold, 3.4-fold, 3.2-fold and 3.3-fold, respectively. The frdA genus has been found to be up-regulated in the M. tuberculosis in (7) as well as in studies that investigated the behaviour of the M. tuberculosis grown under carbon starvation (8). Studies on the behaviour of Mycobacterium phlei found that fumarate reductase (FRD) activity increased fourfold when the bacteria were grown under the low-oxygen conditions (9, 10). Fumarate reductase has reported to be a successful target in treatment of protozoan infections using a variety of compounds (11).
Nitrate reductase is a membrane-bound molybdenum-containing complex (12). Absorption of nitrogen into the mycobacterial metabolism is important for survival of M. tuberculosis (13). It is suggested that the narGHJI mediates nitrate absorption in M. tuberculosis (14).
The pks3 and mmpL10 genes were up-regulated by 3.9-fold and 4.0-fold, respectively. Suppression of papA3 gene expression from the M. tuberculosis resulted in loss of penta-acylated trehalose (PAT) (15-17). Pks3 is a polyketide synthase that is included in PAT biosynthesis of M. tuberculosis (18-20).
The rpsH and rpsS genes were up-regulated by 3.5-fold and 3.3-fold, respectively. Initiation factor infC was up-regulated by 3.7-fold and the transcription level of gene rho was also elevated by 3.4-fold. A work indicated that Clostridium difficile challenge to several concentrations of antibiotics resulted in a general up-regulation of translation machinery (21, 22).
L-arginine metabolism has indicated to be important for the M. tuberculosis (23). Some genes such as argR, argJ, argG, argF and argD were inhibited by 3.5-fold, 3.2-fold, 3.1-fold, 3.1-fold and 3.4-fold, respectively. Suppression of gene expression argR in Legionella pneumophila can affect gene transcript levels predicted to encode terminal steps of L-arginine biosynthesis (24). In Listeria monocytogenes, mutation of argD led to a decreased replication rates in Caco-2 cells (25). In Corynebacterium glutamicum, genes encoding L-arginine biosynthesis proteins showed a decreased expression in ammonium-limited chemostat cultures (26, 27).
The findings of the current study show that the cinnamaldehyde has potential antimycobacterial properties.
The authors would like to acknowledge Ali Mohammadi from the University of Zabol for providing the facilities for the research.
- 1. Rohde KH, Abramovitch RB, Russell DG. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe. 2007;2(5):352-64. [DOI] [PubMed]
- 2. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30(9):eeee36 [PubMed]
- 3. Omura S, Miyadera H, Ui H, Shiomi K, Yamaguchi Y, Masuma R, et al. An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria. Proc Natl Acad Sci U S A. 2001;98(1):60-2. [DOI] [PubMed]
- 4. Bowles BL, Sackitey SK, Williams AC. Inhibitory effects of flavor compounds on Staphylococcus aureus. J Food Saf. 1995;15:337-47.
- 5. Dennis PP. Effects of chloramphenicol on the transcriptional activities of ribosomal RNA and ribosomal protein genes in Escherichia coli. J Mol Biol. 1976;108(3):535-46. [PubMed]
- 6. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002;43(3):717-31. [PubMed]
- 7. Raman S, Song T, Puyang X, Bardarov S, Jacobs WRJr, Husson RN. The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J Bacteriol. 2001;183(20):6119-25. [DOI] [PubMed]
- 8. Bowles BL, Miller AJ. Antibotulinal properties of selected aromatic and aliphatic aldehydes. J Food Prot. 1993;56(9):788-94.
- 9. Golby P, Hatch KA, Bacon J, Cooney R, Riley P, Allnutt J, et al. Comparative transcriptomics reveals key gene expression differences between the human and bovine pathogens of the Mycobacterium tuberculosis complex. Microbiology. 2007;153(Pt 10):3323-36. [DOI] [PubMed]
- 10. Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis. 2003;83:4-14.
- 11. Ormerod LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull. 2005;73-74:17-24. [DOI] [PubMed]
- 12. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol. 2005;5(10):819-26. [DOI] [PubMed]
- 13. Matsuda H, Tomohiro N, Ido Y, Kubo M. Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol. Biol Pharm Bull. 2002;25(6):809-12. [PubMed]
- 14. de la Fuente A, Martin JF, Rodriguez-Garcia A, Liras P. Two proteins with ornithine acetyltransferase activity show different functions in Streptomyces clavuligerus: Oat2 modulates clavulanic acid biosynthesis in response to arginine. J Bacteriol. 2004;186(19):6501-7. [DOI] [PubMed]
- 15. Gordhan BG, Smith DA, Alderton H, McAdam RA, Bancroft GJ, Mizrahi V. Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis. Infect Immun. 2002;70(6):3080-4. [PubMed]
- 16. Hovel-Miner G, Faucher SP, Charpentier X, Shuman HA. ArgR-regulated genes are derepressed in the Legionella-containing vacuole. J Bacteriol. 2010;192(17):4504-16. [DOI] [PubMed]
- 17. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, et al. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med. 2003;198(5):693-704. [DOI] [PubMed]
- 18. Dubourdieu M, DeMoss JA. The narJ gene product is required for biogenesis of respiratory nitrate reductase in Escherichia coli. J Bacteriol. 1992;174(3):867-72. [PubMed]
- 19. Emerson JE, Stabler RA, Wren BW, Fairweather NF. Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J Med Microbiol. 2008;57(Pt 6):757-64. [DOI] [PubMed]
- 20. Nishimura T, Teramoto H, Inui M, Yukawa H. Corynebacterium glutamicum ArnR controls expression of nitrate reductase operon narKGHJI and nitric oxide (NO)-detoxifying enzyme gene hmp in an NO-responsive manner. J Bacteriol. 2014;196(1):60-9. [DOI] [PubMed]
- 21. Dubey VS, Sirakova TD, Kolattukudy PE. Disruption of msl3 abolishes the synthesis of mycolipanoic and mycolipenic acids required for polyacyltrehalose synthesis in Mycobacterium tuberculosis H37Rv and causes cell aggregation. Mol Microbiol. 2002;45(5):1451-9. [PubMed]
- 22. Gillespie J, Barton LL, Rypka EW. Influence of oxygen tension on the respiratory activity of Mycobacterium phlei. J Gen Microbiol. 1988;134(1):247-52. [DOI] [PubMed]
- 23. Hatzios SK, Schelle MW, Holsclaw CM, Behrens CR, Botyanszki Z, Lin FL, et al. PapA3 is an acyltransferase required for polyacyltrehalose biosynthesis in Mycobacterium tuberculosis. J Biol Chem. 2009;284(19):12745-51. [DOI] [PubMed]
- 24. Joseph B, Przybilla K, Stuhler C, Schauer K, Slaghuis J, Fuchs TM, et al. Identification of Listeria monocytogenes genes contributing to intracellular replication by expression profiling and mutant screening. J Bacteriol. 2006;188(2):556-68. [DOI] [PubMed]
- 25. Malm S, Tiffert Y, Micklinghoff J, Schultze S, Joost I, Weber I, et al. The roles of the nitrate reductase NarGHJI, the nitrite reductase NirBD and the response regulator GlnR in nitrate assimilation of Mycobacterium tuberculosis. Microbiology. 2009;155(Pt 4):1332-9. [DOI] [PubMed]
- 26. Domenech P, Reed MB, Barry CE. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect Immun. 2005;73(6):3492-501. [DOI] [PubMed]
- 27. Slayden RA, Knudson DL, Belisle JT. Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis. Microbiology. 2006;152(Pt 6):1789-97. [DOI] [PubMed]